The RETAIN-2 neoadjuvant aMVAC + nivolumab (NCT04506554) trial is following RETAIN (Geynisman et al.) & HCRN trial (Galsky et al.) (both were presented at GU ASCO ’23) in the attempt to assess bladder preservation in localized MIBC. Prospective evaluation of biomarkers in trials is key, but we need more work in biomarker validation.
tematic review and meta-analysis was to generate pooled estimates of the (1) prevalence of mental health problems among parents of children with chronic pain and…
of TMS delivered at maximum intensity using a flat or angulated coil. Magnetic field was recorded by a 3D-magnetic probe. Decay was measured in the…
Extensive evidence documents health disparities for lesbian, gay, and bisexual (LGB) women, including worse physical, mental, and behavioral health than heterosexual women. Sarah McKetta, ScM,…
Amgen performed well in 2023, serving millions of patients around the world with our innovative, life-changing medicines; advancing many promising new first-in-class molecules in our…
Elna Saah, MD joins HCPLive to discuss the current landscape in sickle cell disease and recent advancements benefiting clinical care.
According to a phase 1/2 trial, combining mini-hyper-CVD low-intensity chemotherapy with venetoclax yielded safety and activity among patients with heavily pretreated R/R acute lymphoblastic leukemia.
Planting your own garden puts fresh, healthy veggies right in your back yard! There&rsquo.
Epilepsia is the leading journal for innovative clinical and basic science research for all aspects of epilepsy and seizures, aiming to improve diagnosis and treatment.
Nature Communications – The authors investigate the local/regional nature and associated oxidative potential of PM2.5 emission sources in northern India and show that reducing local…
Nature Aging – In vivo human neuroimaging shows that locus coeruleus (LC) integrity changes precede medial temporal tau accumulation, and jointly predict future lower cognition…
